Sepoy-logo
No Result
View All Result
Sunday, October 1, 2023
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

Common cold coronaviruses may offer pre-existing immunity to COVID-19

Nicholas by Nicholas
August 18, 2023
in Health
0
Common cold coronaviruses may offer pre-existing immunity to COVID-19

Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study involving a Rutgers research scientist.

The study, published in the Journal of Clinical Virology Plus, examined the immune responses in two categories of individuals in Lagos, Nigeria: health care workers in a teaching hospital and members of the general population residing in five localities.

“Of the 83 percent of individuals in our study who had common cold coronavirus exposure, we found that their T cells cross-reacted to SARS-CoV-2, hinting at the fact that people who have been exposed to these genetically related coronaviruses have immune responses that may be protecting them from future SARS-CoV-2 infections,” said Bobby Brooke Herrera, an assistant professor of global health at Rutgers Global Health Institute and a lead author of the study along with Sulaimon Akanmu of Lagos University Teaching Hospital in Nigeria.

The researchers’ findings provide insights about factors that may influence global infectious disease outbreak preparedness and responses, such as vaccine development. Herrera leads a research laboratory that is studying the intricacies of humans’ immune responses to microbial pathogens, especially viruses, that cause lethal human disease and for which there are limited options for treatment or vaccination.

Topics addressed in the study include:

  • Associations between immunity and the Africa paradox of high SARS-CoV-2 infection with low mortality
  • High SARS-CoV-2 seroprevalence in Lagos health care workers and in the community, indicating potentially greater infection rates than reported
  • Laboratory techniques to examine characteristics of pre-existing coronavirus immunity, such as antibodies directed against only the more conserved SARS-CoV-2 nucleocapsid protein as compared to antibodies against both the SARS-CoV-2 nucleocapsid and spike proteins
  • Dynamics associated with prior SARS-CoV-2 infection and a boosted antibody response to the AstraZeneca COVID-19 vaccine
  • Detecting viral exposure by examining T cell responses against SARS-CoV-2 nucleocapsid protein using a novel whole blood test

The results of this study are unique because data was collected at a critical period during the pandemic. Researchers looked at antibody and T cell immune responses of people before and after they were vaccinated. Most people have been exposed to SARS-CoV-2 antigens by either infection or vaccination, Herrera said.

This type of baseline data is now difficult to achieve. However, there are still a lot of unknowns related to COVID-19, and the more we can understand, the better equipped we are to develop improved diagnostics and vaccines for this disease and other infectious diseases.”


Bobby Brooke Herrera, assistant professor of global health, Rutgers Global Health Institute

Herrera’s leadership of this study is an outgrowth of research he was involved with during his time as a visiting scientist at Harvard University in the laboratory of virologist Phyllis J. Kanki, a professor of health sciences at Harvard’s public health school and the study’s senior author.

Herrera is continuing to collaborate with Akanmu, Kanki and others to home in on the mechanisms by which antibodies and T cells may offer protection against future infections by SARS-CoV-2, including its variants. He also is developing T cell-based vaccines.

“I am going to be testing whether the T cell-based vaccines we have developed in my lab and in collaboration with my biotechnology company can protect against multiple SARS-CoV-2 variants as well as some of the genetically similar coronaviruses,” said Herrera, who also is an assistant professor at Rutgers Robert Wood Johnson Medical School and a co-founder of the company Mir Biosciences.

“We’re trying to understand if T cell-based vaccines truly cross-protect,” he said. “We know that they can cross-recognize other coronaviruses, but not whether cross-recognition actually means cross-protection. If it does, that potentially leads to a novel strategy for coronavirus vaccine development.”

Source:

Journal reference:

Akanmu, S., et al. (2023) High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses. Journal of Clinical Virology Plus. doi.org/10.1016/j.jcvp.2023.100156.

READ ALSO

World Heart Day: Mental health support crucial for people with cardiovascular disease

UNH research seeks to quantify health outcomes based on food access, fiber intake and gut microbiota

Tags: AntibodiesAntibodyCellColdCommon ColdCoronaviruscovid-19Global HealthHealth CareHospitalimmunityLaboratoryProteinResearchSARSSARS-CoV-2VaccineVirology

Related Posts

World Heart Day: Mental health support crucial for people with cardiovascular disease
Health

World Heart Day: Mental health support crucial for people with cardiovascular disease

September 30, 2023
UNH research seeks to quantify health outcomes based on food access, fiber intake and gut microbiota
Health

UNH research seeks to quantify health outcomes based on food access, fiber intake and gut microbiota

September 30, 2023
Cancer pathway process can be streamlined with the adoption of AI and automation
Health

Cancer pathway process can be streamlined with the adoption of AI and automation

September 30, 2023
Simple fingerprick blood test could help identify millions of people with undiagnosed diabetes
Health

Simple fingerprick blood test could help identify millions of people with undiagnosed diabetes

September 30, 2023
Cancer cells hijack enhancer DNA to grow faster, study finds
Health

Cancer cells hijack enhancer DNA to grow faster, study finds

September 30, 2023
Stair climbing linked to reduced risk of heart disease, study finds
Health

Stair climbing linked to reduced risk of heart disease, study finds

September 29, 2023
Next Post
Can’t handle peak orders? Scale with on-demand software!

Can’t handle peak orders? Scale with on-demand software!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

POPULAR NEWS

Roblox Is Unbreakable Trello Is this safe?

Roblox Is Unbreakable Trello Is this safe?

November 4, 2022
Discord Registered Games  Discord Registered Gaming You need to join the Club

Discord Registered Games Discord Registered Gaming You need to join the Club

November 4, 2022
How To Chose the Right Data Analytics Program

How To Chose the Right Data Analytics Program

November 4, 2022
Heavy explosion on market square in Halle – three injured

Heavy explosion on market square in Halle – three injured

November 4, 2022

Shivon Zilis Wiki, Height, Age, Boyfriend, Husband, Family, Biography & More

July 11, 2022

EDITOR'S PICK

Demystifying Limited and Regular Pay In Term Insurance

Demystifying Limited and Regular Pay In Term Insurance

February 17, 2023

Four-day week: Which countries have embraced it and how’s it going so far?

June 6, 2022
Top Reasons to Gift Travel Cards

Top Reasons to Gift Travel Cards

May 18, 2023

Best Types of Eye Glasses for Men

July 2, 2022

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: [email protected]

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Zweite Bundesliga am Samstag: St. Pauli nach 2:1 gegen Hertha neuer Tabellenführer
  • Avoiding Pitfalls in Commercial Real Estate Management
  • Empowering Your Workforce: The Key to a Thriving Employee Experience

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net

x